Fabrice Andre's guest appearances

Fabrice Andre

Breast Cancer Update

4th IMPAKT Breast Cancer Conference

Larry Norton

Kent Osborne

Norman Wolmark

Emmanuel S Antonarakis

Johanna Bendell

Ian E Krop

Andrew McKenzie

Mark Robson

Richard Peto

Lewis Cantley

Sanjiv S Agarwala

Sara M Tolaney

Sulfi Ibrahim

Clifford Hudis

Paul E Goss

OwlTail

Prof Fabrice Andre talks to ecancer about identifying patients with a high risk of recurrence at IMPAKT 2012 in Brussels, May 2012. The importance of identifying high risk patients is not just discovering which are the most susceptible to relapse, but to avoid giving a patient a therapy that will have a low effect as well. Prof Andre notes that by using protein based and prognostic biomarkers, the best possible therapy with the lowest risk of relapse, can be identified. The second challenge that Prof Andre addresses is how to bridge the gap between research settings and clinical practice.

Prof Fabrice Andre talks to ecancer about identifying patients with a high risk of recurrence at IMPAKT 2012 in Brussels, May 2012. The importance of identifying high risk patients is not just discovering which are the most susceptible to relapse, but to avoid giving a patient a therapy that will have a low effect as well. Prof Andre notes that by using protein based and prognostic biomarkers, the best possible therapy with the lowest risk of relapse, can be identified. The second challenge that Prof Andre addresses is how to bridge the gap between research settings and clinical practice.

Minimising recurrence by using most effective treatment: Prof Fabrice Andre – Institut Gustave Roussy, Paris, France

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Fabrice Andre, MD, PhD conducted by Neil Love, MD. Produced by Research To Practice.

BCU3 2011 | Interview with Fabrice Andre, MD, PhD